Caricamento...
Long-Term Follow-Up Result of Hydroxyurea Chemotherapy for Recurrent Meningiomas
OBJECTIVE: Meningiomas represent 18-20% of all intracranial tumors and have a 20-50% 10-year recurrence rate, despite aggressive surgery and irradiation. Hydroxyurea, an inhibitor of ribonucleotide reductase, is known to inhibit meningioma cells by induction of apoptosis. We report the long-term fol...
Salvato in:
| Autori principali: | , , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
The Korean Neurosurgical Society
2012
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3550418/ https://ncbi.nlm.nih.gov/pubmed/23346322 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3340/jkns.2012.52.6.517 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|